BioXcel Therapeutics
BTAI
#9826
Rank
โ‚น4.18 B
Marketcap
โ‚น191.56
Share price
-3.18%
Change (1 day)
-70.41%
Change (1 year)

EPS for BioXcel Therapeutics (BTAI)

EPS in 2025 (TTM): -โ‚น1,074

According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น1,137. In 2024 the company made an earnings per share (EPS) of -โ‚น2,328 an increase over its 2023 EPS that were of -โ‚น8,850.

EPS history for BioXcel Therapeutics from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น1,074-53.87%
2024-โ‚น2,328-73.7%
2023-โ‚น8,8504.06%
2022-โ‚น8,50444.85%
2021-โ‚น5,8717.65%
2020-โ‚น5,454

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น155.59-86.31%๐Ÿ‡บ๐Ÿ‡ธ USA